RO HELPS PATIENTS SAVE UP TO $1,200 PER YEAR ON WEGOVY® THROUGH COLLABORATION WITH NOVO NORDISK

The Wegovy® injectable and pill are now available at even lower cash pay prices on Ro NEW YORK, March 31, 2026 /PRNewswire/ -- Ro, the leading direct-to-patient healthcare company, today announced that patients can save up to $1,200/year on the Wegovy® pen or $600/year on the Wegovy® pill...